期刊
CELL REPORTS
卷 35, 期 10, 页码 -出版社
CELL PRESS
DOI: 10.1016/j.celrep.2021.109226
关键词
-
类别
资金
- CIHR [PJT-165821]
- Rare Diseases: Models & Mechanisms Network [27R21814, 27R01299]
- Canadian Gene Cure Advanced Therapies for Rare Diseases (Can-GARD) program
- Azrieli Foundation
- CSM postdoctoral fellowship
- ACHRI postdoctoral fellowship
- Mitacs Globalink
- ACHRI graduate scholarships
- CIHR graduate scholarship
- AGES scholarship
This study reveals that the translocation of CELF2 between subcellular compartments orchestrates mRNA at the translational level to instruct cell fates in cortical development, disrupting NPC fate decisions.
The development of the cerebral cortex requires balanced expansion and differentiation of neural stem/progenitor cells (NPCs), which rely on precise regulation of gene expression. Because NPCs often exhibit transcriptional priming of cell-fate-determination genes, the ultimate output of these genes for fate decisions must be carefully controlled in a timely fashion at the post-transcriptional level, but how that is achieved is poorly understood. Here, we report that de novo missense variants in an RNA-binding protein CELF2 cause human cortical malformations and perturb NPC fate decisions in mice by disrupting CELF2 nucleocytoplasmic transport. In self-renewing NPCs, CELF2 resides in the cytoplasm, where it represses mRNAs encoding cell fate regulators and neurodevelopmental disorder-related factors. The translocation of CELF2 into the nucleus releases mRNA for translation and thereby triggers NPC differentiation. Our results reveal that CELF2 translocation between subcellular compartments orchestrates mRNA at the translational level to instruct cell fates in cortical development.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据